Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Agnosia 1

Interventions

Saline Solution 2Oxycodone 2Methods 2Acetaminophen 2siltuximab 1pegfilgrastim 1oxycodone-acetaminophen 1erenumab 1Xylitol 1Therapeutics 1Telemedicine 1Surveys and Questionnaires 1STAMP-I protocol 1Remifentanil 1Range of Motion, Articular 1Physical Therapy Modalities 1Myofascial Release Therapy 1Music Therapy 1Morphine 1Methadone 1Massage 1Kyphoplasty 1Ketorolac Tromethamine 1Ketorolac 1High-Energy Shock Waves 1Electroacupuncture 1Early Intervention, Educational 1Chewing Gum 1Case Management 1Betaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × STAMP-I protocol × 90 days × Clear all
NCT06117709 2026-03-19

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

Dana-Farber Cancer Institute

Phase NA Not yet recruiting
73 enrolled

Agnosia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡